No abstract available
MeSH terms
-
Antidiuretic Hormone Receptor Antagonists
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzazepines / therapeutic use
-
Dacarbazine / administration & dosage
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Diagnosis, Differential
-
Disease Progression
-
Doxorubicin / administration & dosage
-
Gemcitabine
-
Humans
-
Hyponatremia / drug therapy
-
Hyponatremia / etiology
-
Ifosfamide / administration & dosage
-
Immunohistochemistry
-
Immunophenotyping
-
Inappropriate ADH Syndrome / diagnosis*
-
Inappropriate ADH Syndrome / pathology
-
Juxtaglomerular Apparatus / pathology*
-
Kidney Neoplasms / chemistry
-
Kidney Neoplasms / complications
-
Kidney Neoplasms / diagnosis*
-
Kidney Neoplasms / drug therapy
-
Kidney Neoplasms / pathology
-
Luminescent Measurements
-
Male
-
Middle Aged
-
Neoplasms, Multiple Primary / chemistry
-
Neoplasms, Multiple Primary / complications
-
Neoplasms, Multiple Primary / diagnosis*
-
Neoplasms, Multiple Primary / drug therapy
-
Neoplasms, Multiple Primary / pathology
-
Paclitaxel / administration & dosage
-
Paraneoplastic Syndromes / pathology*
-
Renin / immunology
-
Renin / isolation & purification*
-
Tolvaptan
-
Vinblastine / administration & dosage
-
Vinblastine / analogs & derivatives
-
Vinorelbine
Substances
-
Antidiuretic Hormone Receptor Antagonists
-
Benzazepines
-
Deoxycytidine
-
Tolvaptan
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Renin
-
Paclitaxel
-
Vinorelbine
-
Ifosfamide
-
Gemcitabine